Navigation Links
Newly Formed American Society for Nanomedicine (ASNM) to Hold First Conference (

ASHBURN, Va., Sept. 4 /PRNewswire-USNewswire/ -- Nanomedicine - the science and technology of diagnosing, treating and preventing disease to improve human health using nanotechnology - has the potential to revolutionize healthcare. Current and future products range from miniaturized "smart pills" that precision-target certain cancers to nanosensors that are capable of navigating through the body for early detection of disorders. These approaches have the ability to reduce toxicity for the patient, thereby improving efficacy and patient compliance. The newly formed American Society for Nanomedicine (ASNM) is holding its inaugural conference on October 22-25, 2009 in the Washington D.C. area, where some of the biggest stakeholders in this emerging technology operate and practice.

This major interdisciplinary international conference is designed for physicians, scientists, policy-makers, engineers, lawyers and educators from government, academia and industry. The conference venue is the Bolger Center in Potomac, Maryland, USA (

This four-day conference will highlight numerous cutting-edge presentations broken up into various sessions focusing on innovations in nanomedicine and applications of nanotechnology to the pharmaceutical, device and biotechnology industries. It will feature more than forty speakers, who are among the top researchers and leaders in various facets of nanomedicine throughout the world. The areas of emphasis are clinical applications of nanotechnology enabling successful vaccine development, effective cancer therapy and novel drug delivery approaches. In addition, issues such as ethics, safety and toxicity, patent law, intellectual property and commercialization will be addressed. Poster sessions, an award ceremony and numerous networking opportunities are included.

About American Society for Nanomedicine

American Society for Nanomedicine (ASNM) is a professional non-profit, medical society headquartered in Ashburn, Virginia, USA. It promotes worldwide seminal research activities in nanomedicine and explores the applications of nanotechnology in the pharmaceutical, device and biotechnology industries. Members also discuss issues such as ethics, toxicity, patents and commercialization. They are drawn from diverse and overlapping fields such as biotechnology, engineering, medicine, policy and law. Members enjoy numerous benefits, including reduced rates to attend ASNM conferences and discounted rates to ASNM-affiliated journals.


Dr. Esther Chang, Acting President, American Society for Nanomedicine; Professor of Oncology, Georgetown University Medical Center, Washington, D.C., USA; Phone: +202 687 8418

Dr. Raj Bawa, Acting Secretary, American Society for Nanomedicine; President, Bawa Biotechnology Consulting, 21005 Starflower Way, Ashburn, Virginia, USA; Phone: +703 582 1745

Conference Information/Registration:

SOURCE American Society for Nanomedicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Familiar and newly learned words are processed by the same neural networks in the brain
2. Newly discovered mechanism in cell division has implications for chromosomes role in cancer
3. MRI may be unnecessary prior to treatment in most newly diagnosed breast cancer patients
4. Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination
5. Exploring Newly Found Freedom with the GaitAid for Parkinson's Disease
6. Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report
7. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
8. ONRAD Announces Newly Bundled Services for a Single Package Price
9. Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation
10. Newly Patented Sterilization/Disinfection Method Reduces Risk of Microorganism Growth on Hard Surfaces
11. Accumetrics VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly-Approved Prasugrel (Effient(R))
Post Your Comments:
(Date:11/26/2015)... BOSTON, Mass. (PRWEB) , ... November 26, 2015 ... ... a thorough second medical opinion process, participated in the 61st annual Employee Benefits ... Benefit Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology: